From the *Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Ohio; †Department of Anesthesiology and Reanimation, Etimesgut Military Hospital, Ankara/Turkey; and ‡Department of Quantitative Health Sciences, Anesthesiology Institute, Cleveland Clinic, Ohio.
Anesth Analg. 2017 Apr;124(4):1118-1126. doi: 10.1213/ANE.0000000000001911.
Systemic lupus erythematosus (SLE) is a common autoimmune connective tissue disease that mainly harms kidneys, heart, lungs, and nervous system. Effects of surgical stimulus and anesthesia combined with SLE-related pathologies may increase morbidity and mortality. Therefore, we aimed to evaluate the association between SLE (versus none) and postoperative renal, cardiac, and in-hospital mortality complications among patients undergoing major surgeries.
We obtained censuses of 2009 to 2011 inpatient hospital discharges across 7 states and conducted a retrospective cohort study by using International Classification of Diseases and Injuries, Version 9, diagnosis codes, procedure codes, and present-on-admission indicators. We included patients who had major surgery and matched each SLE discharge up to 4 control discharges for potential confounders. We assessed the association between matched SLE patients and controls on in-hospital renal complications, cardiovascular complications, and in-hospital mortality using separate logistic regression models.
Among 8 million qualifying discharges, our sample contained 28,269 SLE patients matched with 13,269 controls. SLE was associated with a significantly higher risk of postoperative renal complications, with an estimated odds ratio (99% CI) of 1.33 (1.21, 1.46); P < .001. In addition, SLE was significantly associated with a higher risk of in-hospital mortality, with an estimated odds ratio (99% CI) of 1.27 (1.11, 1.47); P < .001. However, we found no significant association between SLE and cardiac complications, with an estimated odds ratio (99% CI) of 0.98 (0.83, 1.16), P = .79.
This is, by far, the largest clinical study for postoperative outcomes of SLE patients with adequately powered statistical analyses. We concluded that SLE was associated with a higher risk of renal complications and in-hospital mortality but not cardiac events after major surgery. In SLE patients, more aggressive measures should be taken to prevent renal injury in the perioperative period.
系统性红斑狼疮(SLE)是一种常见的自身免疫性结缔组织疾病,主要损害肾脏、心脏、肺和神经系统。手术刺激和麻醉与 SLE 相关病理的结合可能会增加发病率和死亡率。因此,我们旨在评估 SLE(与无 SLE 相比)与接受大手术的患者术后肾脏、心脏和院内死亡率并发症之间的关系。
我们从 2009 年至 2011 年获得了 7 个州的住院患者住院记录,并通过使用国际疾病分类和伤害版本 9、诊断代码、程序代码和入院时指标进行了回顾性队列研究。我们纳入了接受大手术的患者,并为每个 SLE 出院患者匹配了多达 4 个对照出院患者,以调整潜在的混杂因素。我们使用单独的逻辑回归模型评估了匹配的 SLE 患者与对照者之间的院内肾脏并发症、心血管并发症和院内死亡率之间的关系。
在符合条件的 800 万出院患者中,我们的样本包含了 28269 名 SLE 患者,与 13269 名对照患者相匹配。SLE 与术后肾脏并发症的风险显著增加相关,估计比值比(99%置信区间)为 1.33(1.21,1.46);P<0.001。此外,SLE 与院内死亡率的风险显著增加相关,估计比值比(99%置信区间)为 1.27(1.11,1.47);P<0.001。然而,我们发现 SLE 与心脏并发症之间没有显著关联,估计比值比(99%置信区间)为 0.98(0.83,1.16),P=0.79。
这是迄今为止针对 SLE 患者术后结局的最大规模临床研究,具有足够的统计分析能力。我们的结论是,SLE 与术后肾脏并发症和院内死亡率的风险增加相关,但与心脏事件无关。在 SLE 患者中,应在围手术期采取更积极的措施来预防肾脏损伤。